(Q36116456)

12 August 2017

1 reference

title

Pharmacokinetics of proton pump inhibitors in children (English)

1 reference

12 August 2017

1 reference

Catherine Litalien

1

1 reference

12 August 2017

Yves Théorêt

series ordinal

2

1 reference

12 August 2017

Christophe Faure

series ordinal

3

1 reference

12 August 2017

1 January 2005

1 reference

Clinical Pharmacokinetics

12 August 2017

1 reference

12 August 2017

44

1 reference

12 August 2017

5

1 reference

12 August 2017

441-466

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200544050-00001

12 August 2017

0 references

cites work

The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog

1 reference

12 December 2020

Omeprazole in infants with cimetidine-resistant peptic esophagitis.

1 reference

12 December 2020

Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole

1 reference

12 December 2020

Interethnic difference in omeprazole's inhibition of diazepam metabolism.

1 reference

12 December 2020

Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation

1 reference

12 December 2020

1 reference

12 December 2020

Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizers

1 reference

12 December 2020

Helicobacter pylori Infection in Children: Recommendations for Diagnosis and Treatment

1 reference

12 December 2020

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

1 reference

12 December 2020

Pharmacogenetics in pediatrics. Implications for practice

1 reference

12 December 2020

Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole

1 reference

12 December 2020

Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation

1 reference

12 December 2020

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

1 reference

12 December 2020

Effectiveness and pharmacokinetics of omeprazole in children with refractory duodenal ulcer

1 reference

12 December 2020

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

1 reference

12 December 2020

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

12 December 2020

Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity

1 reference

12 December 2020

Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms

1 reference

12 December 2020

Proton pump inhibitors: better acid suppression when taken before a meal than without a meal

1 reference

12 December 2020

Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood.

1 reference

12 December 2020

CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori

1 reference

12 December 2020

Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality.

1 reference

12 December 2020

Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution

1 reference

12 December 2020

Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children

1 reference

12 December 2020

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

12 December 2020

Early development of human gastric H,K-adenosine triphosphatase

1 reference

12 December 2020

Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy

1 reference

12 December 2020

One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection

1 reference

12 December 2020

Histological esophagitis: clinical and histological response to omeprazole in children

1 reference

12 December 2020

Omeprazole for severe reflux esophagitis in children

1 reference

12 December 2020

Single-enantiomer drugs: elegant science, disappointing effects

1 reference

12 December 2020

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

1 reference

12 December 2020

Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease

1 reference

12 December 2020

Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.

1 reference

12 December 2020

Omeprazole: therapy of choice in intellectually disabled children

1 reference

12 December 2020

Proton pump inhibitors and acid-related diseases

1 reference

12 December 2020

Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments

1 reference

12 December 2020

Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers

1 reference

12 December 2020

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

12 December 2020

Omeprazole pharmacodynamics and gastric acid suppression in critically ill pediatric transplant patients

1 reference

12 December 2020

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

1 reference

12 December 2020

Efficacy and safety of omeprazole for severe gastroesophageal reflux in children.

1 reference

12 December 2020

Effective 2-wk therapy for Helicobacter pylori disease in children

1 reference

12 December 2020

Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations

1 reference

12 December 2020

Pharmacokinetics--a relevant factor for the choice of a drug?

1 reference

12 December 2020

Pharmacokinetic interaction between lansoprazole and theophylline

1 reference

12 December 2020

Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes

1 reference

12 December 2020

Pharmacokinetics of intravenous omeprazole in children

1 reference

12 December 2020

Gastric acid secretion in preterm infants.

1 reference

12 December 2020

Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children

1 reference

12 December 2020

Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure

1 reference

12 December 2020

Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose

1 reference

12 December 2020

Proton pump inhibitors and their drug interactions: an evidence-based approach

1 reference

12 December 2020

Inhibition of gastric acid secretion by omeprazole in the dog and rat

1 reference

12 December 2020

Gastric acid secretory function in preterm infants.

1 reference

12 December 2020

Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion

1 reference

12 December 2020

Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions.

1 reference

12 December 2020

A review of omeprazole use in the treatment of acid-related disorders in children

1 reference

12 December 2020

Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype

1 reference

12 December 2020

1 reference

12 December 2020

No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Omeprazole disposition in children following single-dose administration

1 reference

12 December 2020

A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection

1 reference

12 December 2020

ENT manifestations of gastroesophageal reflux

1 reference

12 December 2020

Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

1 reference

12 December 2020

Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate

1 reference

12 December 2020

Omeprazole reduces preoperative gastric fluid acidity and volume in children.

1 reference

12 December 2020

A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection

1 reference

12 December 2020

Clinical pharmacokinetics of lansoprazole.

1 reference

12 December 2020

Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol

1 reference

12 December 2020

Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects

1 reference

12 December 2020

Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis

1 reference

12 December 2020

Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori

1 reference

12 December 2020

Oral phenytoin pharmacokinetics during omeprazole therapy

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with impaired renal function

1 reference

12 December 2020

A randomized comparison of triple therapy Helicobacter pylori eradication regimens in children with peptic ulcers

1 reference

12 December 2020

Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes

1 reference

12 December 2020

Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19.

1 reference

12 December 2020

The use of proton pump inhibitors in children: a comprehensive review

1 reference

12 December 2020

Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children

1 reference

12 December 2020

Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements

1 reference

12 December 2020

Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects

1 reference

12 December 2020

Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin

1 reference

12 December 2020

Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.

1 reference

12 December 2020

Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders

1 reference

12 December 2020

Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.

1 reference

12 December 2020

Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole

1 reference

12 December 2020

Alteration of drug biotransformation and elimination during infection and inflammation

1 reference

12 December 2020

Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

1 reference

12 December 2020

Failure of nasogastric omeprazole suspension in pediatric intensive care patients

1 reference

12 December 2020

Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney.

1 reference

12 December 2020

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

12 December 2020

Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction

1 reference

12 December 2020

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects

1 reference

12 December 2020

Supraesophageal complications of gastroesophageal reflux in children: challenges in diagnosis and treatment

1 reference

12 December 2020

Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19

1 reference

12 December 2020

Development of the human gastrointestinal tract. A review

1 reference

12 December 2020

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.

1 reference

12 December 2020

Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19.

1 reference

12 December 2020

Lansoprazole and omeprazole in the treatment of acid peptic disorders.

1 reference

12 December 2020

Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells

1 reference

12 December 2020

Interaction of omeprazole with enteric-coated salicylate tablets.

1 reference

12 December 2020

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

1 reference

12 December 2020

A study of the interaction between omeprazole and phenytoin in epileptic patients

1 reference

12 December 2020

Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers.

1 reference

12 December 2020

Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections

1 reference

12 December 2020

Gastro-oesophageal reflux treatment for asthma in adults and children

1 reference

12 December 2020

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

1 reference

12 December 2020

Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

1 reference

12 December 2020

Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.

1 reference

12 December 2020

One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents

1 reference

12 December 2020

Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline

1 reference

12 December 2020

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

1 reference

12 December 2020

Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis.

1 reference

12 December 2020

Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.

1 reference

12 December 2020

Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.

1 reference

12 December 2020

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

12 December 2020

Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure.

1 reference

12 December 2020

Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group

1 reference

12 December 2020

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status

1 reference

12 December 2020

Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects

1 reference

12 December 2020

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

1 reference

12 December 2020

Lansoprazole reduces preoperative gastric fluid acidity and volume in children.

1 reference

12 December 2020

Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis

1 reference

12 December 2020

Twenty-four hour intragastric acidity during treatment with oral omeprazole.

1 reference

12 December 2020

Pharmacokinetics of pantoprazole in man.

1 reference

12 December 2020

Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders

1 reference

12 December 2020

Omerprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children

1 reference

12 December 2020

The pharmacology of the gastric acid pump: the H+,K+ ATPase

1 reference

12 December 2020

Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.

1 reference

12 December 2020

Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole

1 reference

12 December 2020

Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes

1 reference

12 December 2020

Effects of lansoprazole on pharmacokinetics and metabolism of theophylline

1 reference

12 December 2020

Clinical pharmacology of omeprazole

1 reference

12 December 2020

Omeprozole therapy in pediatric patients after liver and intestinal transplantation

1 reference

12 December 2020

Pharmacokinetics and absolute bioavailability of lansoprazole

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis

1 reference

12 December 2020

Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers.

1 reference

12 December 2020

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

12 December 2020

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease.

1 reference

12 December 2020

1 reference

12 December 2020

Basal and Pentagastrin-Stimulated Acid Secretion in Newborn Human Infants

1 reference

12 December 2020

Update on gastroesophageal reflux disease in pediatric airway disorders

1 reference

12 December 2020

Proton pump inhibitors--differences emerge in hepatic metabolism

1 reference

12 December 2020

Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.

1 reference

12 December 2020

The use of omeprazole for resistant oesophagitis in children

1 reference

12 December 2020

Pharmacokinetic study of esomeprazole in patients with hepatic impairment

1 reference

12 December 2020

Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs

1 reference

12 December 2020

Optimizing the intragastric pH as a supportive therapy in upper GI bleeding

1 reference

12 December 2020

Stereoselective interaction of omeprazole with warfarin in healthy men

1 reference

12 December 2020

Effect of omeprazole and cimetidine on plasma diazepam levels.

1 reference

12 December 2020

Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis

1 reference

12 December 2020

Resolution of the enantiomers of omeprazole and some of its analogues by liquid chromatography on a trisphenylcarbamoylcellulose-based stationary phase. The effect of the enantiomers of omeprazole on gastric glands

1 reference

12 December 2020

Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux

1 reference

12 December 2020

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders

1 reference

12 December 2020

The effects of oral doses of lansoprazole and omeprazole on gastric pH

1 reference

12 December 2020

Role of gastroesophageal reflux in older children with persistent asthma.

1 reference

12 December 2020

Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects

1 reference

12 December 2020

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders

1 reference

12 December 2020

Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know

1 reference

12 December 2020

Pharmacokinetics of omeprazole in healthy adults and in children with gastroesophageal reflux disease

1 reference

12 December 2020

Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.

1 reference

12 December 2020

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity

1 reference

12 December 2020

A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.

1 reference

12 December 2020

Single-isomer drugs: true therapeutic advances

1 reference

12 December 2020

Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children

1 reference

12 December 2020

Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders

1 reference

12 December 2020

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

12 December 2020

Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

1 reference

12 December 2020

Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration

1 reference

12 December 2020

Effects of a proton-pump inhibitor in cystic fibrosis

1 reference

12 December 2020

Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity.

1 reference

12 December 2020

Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules

1 reference

12 December 2020

Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.

1 reference

12 December 2020

The effect of food and antacids on lansoprazole absorption and disposition

1 reference

12 December 2020

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

1 reference

12 December 2020

The pharmacokinetics of omeprazole in humans--a study of single intravenous and oral doses

1 reference

12 December 2020

10.2165/00003088-200544050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1037288403

0 references

Fatcat ID

release_7mlnhqgpmvcgje4l322k7ato7e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7mlnhqgpmvcgje4l322k7ato7e

24 November 2022

mapped directly with Wikidata item

1 reference